WO2002102347A2 - Method for the preparation of an active component rich in di- and tri-peptides, active component and compositions thus obtained - Google Patents

Method for the preparation of an active component rich in di- and tri-peptides, active component and compositions thus obtained Download PDF

Info

Publication number
WO2002102347A2
WO2002102347A2 PCT/FR2002/002114 FR0202114W WO02102347A2 WO 2002102347 A2 WO2002102347 A2 WO 2002102347A2 FR 0202114 W FR0202114 W FR 0202114W WO 02102347 A2 WO02102347 A2 WO 02102347A2
Authority
WO
WIPO (PCT)
Prior art keywords
bacterial
less
active principle
daltons
medium
Prior art date
Application number
PCT/FR2002/002114
Other languages
French (fr)
Other versions
WO2002102347A3 (en
Inventor
Jean-Jacques Paufique
Original Assignee
Societe Industrielle Limousine D'application Biologique (Silab)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8864499&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2002102347(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Societe Industrielle Limousine D'application Biologique (Silab) filed Critical Societe Industrielle Limousine D'application Biologique (Silab)
Publication of WO2002102347A2 publication Critical patent/WO2002102347A2/en
Publication of WO2002102347A3 publication Critical patent/WO2002102347A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/645Proteins of vegetable origin; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to a process for the preparation of an active principle rich in di- and tri-peptides.
  • the invention also covers the active ingredient obtained as well as compositions incorporating it.
  • the purpose of the active ingredient thus extracted is in particular to improve cell proliferation, to compensate for stress, to improve the essential balance for cellular dietetics, to increase the defenses of the skin, to increase the oxygenation of the skin and decrease wrinkles.
  • the active principle according to the present invention makes it possible to rapidly supply nutritional elements to the skin by the remarkable assimilation capacities which it exhibits.
  • This strong assimilation capacity is based on the fact that its peptide structure has a low molecular weight.
  • a process for manufacturing a hydrolyzate of proteins rich in di- and tri-peptides for artificial nutrition and used in dietetics.
  • This process consists in subjecting an egg white protein or casein protein to the simultaneous or successive action of enzymes, in this case a bacterial protease usable in neutral medium, a bacterial protease usable in alkaline medium and an enzyme pancreatic animal.
  • enzymes in this case a bacterial protease usable in neutral medium, a bacterial protease usable in alkaline medium and an enzyme pancreatic animal.
  • the purpose of the present invention is to obtain a protein hydrolyzate with a low molecular weight to be absorbed by the skin.
  • the invention is now described in detail, both in its stages of production and in the characterization of the active ingredient obtained and with regard to test results showing the activities of the product obtained.
  • the description is focused on an example from vegetable proteins obtained from rice (Oryza Sativa) but should be extended as indicated in the additional examples for, among others, soybeans (Glycine max), pumpkin seeds ( Cucurbita Pepo) or sesame (Sesamum indicum) or peas (Pisum Sativum) or lupine (Lupinus albus), cashew, sisymbre, or almonds. More generally, for the implementation of the method according to the invention and for the preparation of the products from this method, all vegetable proteins derived from flour, meal, isolate, concentrate and all protein from animal or marine origin.
  • the invention relates to a method of extracting an active principle having a nutritional action from the skin, characterized in that it comprises the succession of the following stages:
  • concentration of the active fraction in small peptides with a molecular mass of less than 1400 daltons concentration of the active fraction in small peptides with a molecular mass of less than 1400 daltons
  • Vegetable proteins are obtained from cereals, oilseeds, legumes and more particularly rice (Orysa Sativa), soybeans (Glycine max), pumpkin seeds, sesame (Sesamum indicum) or peas (Pinu sativum)
  • the active ingredient obtained by implementing the process has:
  • a protein content is between 40.0 and 60.0 g / 1.
  • the molecular mass is distributed as follows:
  • the invention also covers the nutritional cosmetic composition comprising 0.10% to 5.00% of active principle, associated with excipients and in a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution.
  • a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution.
  • FIG. 1 a distribution curve of the peptide fractions obtained in the case of rice
  • FIGS. 7A and 7B tables of results of analyzes on volunteers concerning tissue oxygenation
  • the first product according to the invention from which it is desired to obtain a concentrate rich in di and tri peptides constituting the active principle according to the invention, is rice, including the variety Orysa Sativa.
  • the process consists of carrying out the following steps:
  • a curve shown in FIG. 1 is produced on a column sold under the name Superdex Peptide. Using a 0.02 mol phosphate buffer solution added with 0.25 mol NaCl and working at pH 7.2.
  • the flow rate on the column is 0.25 ml / min and is expressed on paper by 0.25 cm / min.
  • the dry matter content is obtained by passing the active ingredient extracted in an oven at 105 ° C until a constant weight is obtained.
  • the amount of dry matter obtained, for each of them, is between 50 and 150 g / 1.
  • Dry soybean content between 50 and 60g / l
  • Rate of sesame dry matter between 50 and 60g / l
  • Pea dry matter rate between 90 and HOg / l
  • the pH is measured by the potentiometric method at room temperature.
  • the pH is between 4.0 and 10, more particularly between 5.0 and 7.0.
  • pH of rice 7.0 pH of pumpkin seeds: 7.0 pH of soybeans: 7.0 pH of sesame: 7.0 pH of peas: 7.0
  • Determination of the nitrogen content The determination is carried out by the method of Kjeldhal or Lowry.
  • the deduced protein content is between 10 and 100 g / 1 and more particularly between 35 and 90 g / 1.
  • Nitrogen content (Di- and Tri-rice peptides): between 35 and 90g / l Nitrogen content (Di- and Tri-pumpkin seed peptides): between 30 and 60g / l Nitrogen content (Di- and Tri - soy peptides): between 30 and 60g / l Nitrogen content (Di- and Tri-sesame peptides): between 30 and 60g / l Nitrogen content (Di- and Tri-pea peptides): between 70 and 100g / l
  • the tests are performed after 48 and 72 hours, while the tests are analyzed only after 72 hours for the active ingredient from other basic products, the percentage of proliferation is measured.
  • the active ingredient rich in di- and tri-peptides strongly increases the proliferation of cells, in a dose-dependent manner, more particularly after 72 hours of treatment.
  • the aim is to study the influence of the biochemical structure of the active principle on the metabolism of human f ibroblasts in culture.
  • compositions on proliferation are compared after 72 hours of treatment with the active principle according to the present invention obtained from: - rice with 75% peptides with a molecular mass of less than 1,400 daltons.
  • the cell viability of human fibroblasts subjected to UVA and UVB irradiation is measured, whether or not the active principle according to the present invention is present after 48 or 72 hours.
  • the doses are 6 joules / cm 2 in UVA and 0.48 joules / cm 2 in UVB and the results are expressed in optical density at 540 nm.
  • the active principle derived from rice proteins, has an action on the messenger RNA coding for collagens VII and III and fibronectin in nutrient deficiency medium.
  • human fibroblasts are incubated in a complete medium and in a nutrient deficiency medium, in the presence of the active principle.
  • results obtained are substantially identical and are expressed as a percentage of expression of the RNA of the protein studied compared to a control. They are shown in the table in Figure 5.
  • the active ingredient significantly increases the expression of mRNAs encoding collagens III, VII and fibronectin, therefore constitutive proteins of the dermis.
  • the active principle helps maintain the balance essential for cellular dietetics.
  • the objective of this study is to quantify, in vivo, on humans, the oxygenating effect of the active ingredient, obtained from rice proteins.
  • the partial pressures of oxygen and carbon dioxide transcutaneous on a zone treated with a formulation at 4% of the active principle against placebo are measured.
  • the measurements are taken before and after 28 days of twice-daily application of the active principle.
  • the partial pressure measurements are carried out in a known manner for oxygen by measuring the variations in electric microcurrents and for carbon dioxide by determining the pH of an electrolyte also by measuring the variations in electric microcurrents. Changes in pH are proportional to the logarithm of changes in partial pressure of carbon dioxide. The measurements are expressed in mm of mercury.
  • FIGS. 7A and 7B group together the very similar results for the active principle and show an increase in the partial pressure of oxygen in 54% of the volunteers and in the partial pressure of O2 in 61% of the volunteers. Thus, it is found that the active principle tends to allow better diffusion of oxygen in cells and tissues.
  • the aim of the study is to check the anti-wrinkle efficacy of the active ingredient formulated at 5% against placebo on 20 volunteers, applied twice daily for two months.
  • the anti-wrinkle study consists of analyzing by observing the footprints of crow's feet, using a profilometer equipped with an image analyzer.
  • the four parameters studied are:
  • the results are grouped in the table in FIG. 8.
  • the analysis shows a sharp reduction of 32% in the total wrinkled surface and in 24% in the length of the wrinkles and the distribution confirms that this reduction interests 70% of the volunteers.
  • the invention also covers nutritional cosmetic compositions including, 0.10% to 5.00% of active principle, associated with excipients, in a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution. .

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention relates to a method for the extraction of an active component with a nutritional effect on the skin, characterised in comprising the following steps: solubilisation of animal, vegetable or fish proteins in water, with a proportion of at least 5 % by weight; simultaneous or successive hydrolysis of the above suspension in the presence of one or several enzymes chosen from bacterial aminopeptidases applicable in neutral or acid medium, animal stomach proteases applicable in an acid medium, bacterial proteases applicable in a neutral medium, bacterial proteases applicable in an alkaline medium extracted from Bacillus Licheniformis or Bacillus Subtilis, bacterial endoproteases or pancreatic enzymes of animal origin; concentration of the active fraction of small peptides of molecular mass less than 1400 daltons and a sterilising filtration to give a total mesophilic flora of less than 100 germs/g and an absence of yeasts and moulds. The invention also relates to obtained active component and the cosmetic compositions comprising the above.

Description

PROCEDE DE PREPARATION D'UN PRINCIPE ACTIF RICHE EN DI- ET TRI-PEPTIDES, PRINCIPE ACTIF ET COMPOSITIONS OBTENUS PROCESS FOR THE PREPARATION OF AN ACTIVE INGREDIENT RICH IN DI- AND TRI-PEPTIDES, ACTIVE INGREDIENT AND COMPOSITIONS OBTAINED
Lα présente invention concerne un procédé de préparation d'un principe actif riche en di- et tri-peptides. L'invention couvre aussi le principe actif obtenu ainsi que des compositions l'incorporant.The present invention relates to a process for the preparation of an active principle rich in di- and tri-peptides. The invention also covers the active ingredient obtained as well as compositions incorporating it.
Le but du principe actif ainsi extrait est notamment d'améliorer la prolifération cellulaire, de compenser le stress, d'améliorer l'équilibre indispensable à la diététique cellulaire, d'augmenter les défenses de la peau, d'augmenter l'oxygénation de la peau et de diminuer les rides.The purpose of the active ingredient thus extracted is in particular to improve cell proliferation, to compensate for stress, to improve the essential balance for cellular dietetics, to increase the defenses of the skin, to increase the oxygenation of the skin and decrease wrinkles.
Dans le cas de la peau, le principe actif selon la présente invention permet d'apporter rapidement des éléments nut itionnels à la peau par les remarquables capacités d'assimilation qu'il présente.In the case of the skin, the active principle according to the present invention makes it possible to rapidly supply nutritional elements to the skin by the remarkable assimilation capacities which it exhibits.
Cette forte capacité d'assimilation repose sur le fait que sa structure peptidique a un faible poids moléculaire.This strong assimilation capacity is based on the fact that its peptide structure has a low molecular weight.
Ces unités peptidiques purifiées ainsi apportées accélèrent l'assimilation cellulaire et vitalisent la peau. Une peau ainsi nourrie et revitalisée permet aussi de lutter contre le vieillissement tissulaire et notamment de combler les rides.These purified peptide units thus provided accelerate cellular assimilation and vitalize the skin. Skin thus nourished and revitalized also helps to fight against tissue aging and in particular to fill in wrinkles.
Dans l'art antérieur, il a été décrit un procédé de fabrication d'un hydrolysat de protéines riches en di- et tri-peptides pour la nutrition artificielle et utilisées en diététique. Ce procédé consiste à soumettre une protéine du blanc d'oeuf ou de la caséine, à l'action simultanée ou successive d'enzymes, en l'occurrence une protéase bactérienne utilisable en milieu neutre, une protéase bactérienne utilisable en milieu alcalin et une enzyme pancréatique d'origine animale. Le but de lα présente invention est d'obtenir un hydrolysat de protéines avec un faible poids moléculaire pour être absorbée par la peau.In the prior art, a process has been described for manufacturing a hydrolyzate of proteins rich in di- and tri-peptides for artificial nutrition and used in dietetics. This process consists in subjecting an egg white protein or casein protein to the simultaneous or successive action of enzymes, in this case a bacterial protease usable in neutral medium, a bacterial protease usable in alkaline medium and an enzyme pancreatic animal. The purpose of the present invention is to obtain a protein hydrolyzate with a low molecular weight to be absorbed by the skin.
Dans l'art antérieur, le secteur concerné est l'alimentation artificielle si bien que le poids moléculaire n'est pas une contrainte. Par contre ces produits obtenus par les procédés connus ne permettent pas d'applications en cosmétologie.In the prior art, the sector concerned is artificial feeding so that the molecular weight is not a constraint. On the other hand, these products obtained by known methods do not allow applications in cosmetology.
L'invention est maintenant décrite en détail, tant dans ses étapes d'obtention que dans la carac é isa ion du principe actif obtenu et à iravers des résultats d'essais montrant les activités du produit obtenu. La description est focalisée sur un exemple à partir de protéines végétales obtenues à partir de riz (Oryza Sativa) mais doit être élargi comme cela est indiqué dans les exemples complémentaires pour, entre autres, du soja (Glycine max), des pépins de courges (Cucurbita Pepo) ou de sésame (Sesamum indicum) ou des pois (Pisum Sativum) ou encore du lupin (Lupinus albus), du cajou, du sisymbre, ou des amandes. Plus généralement, pour la mise en œuvre du procédé selon l'invention et pour l'élaboration des produits à partir de ce procédé, on retiendra toutes protéines végétales issues de farine, du tourteau, d'isolat, de concentrât et toutes protéines d'origine animale ou marine. L'invention concerne un procédé d'extraction d'un principe actif ayant une action nutritionnelle de la peau, caractérisé en ce qu'il comprend la succession des étapes suivantes :The invention is now described in detail, both in its stages of production and in the characterization of the active ingredient obtained and with regard to test results showing the activities of the product obtained. The description is focused on an example from vegetable proteins obtained from rice (Oryza Sativa) but should be extended as indicated in the additional examples for, among others, soybeans (Glycine max), pumpkin seeds ( Cucurbita Pepo) or sesame (Sesamum indicum) or peas (Pisum Sativum) or lupine (Lupinus albus), cashew, sisymbre, or almonds. More generally, for the implementation of the method according to the invention and for the preparation of the products from this method, all vegetable proteins derived from flour, meal, isolate, concentrate and all protein from animal or marine origin. The invention relates to a method of extracting an active principle having a nutritional action from the skin, characterized in that it comprises the succession of the following stages:
- solubilisation de protéines végétales, animales ou marines dans l'eau, à raison d'au moins 5% en poids.- solubilization of vegetable, animal or marine proteins in water, at a rate of at least 5% by weight.
- hydrolyse(s) simultanée(s) et/ou successives de cette suspension en présence d'une ou plusieurs enzymes choisies parmi les :- simultaneous and / or successive hydrolysis (s) of this suspension in the presence of one or more enzymes chosen from:
- aminopeptidases bactériennes en milieu neutre ou acide,- bacterial aminopeptidases in neutral or acidic medium,
- proteases stomacales d'origine animale utilisables en milieu acide,- stomach proteases of animal origin usable in an acid medium,
- proteases bactériennes en milieu neutre, - proteases bactériennes utilisables en milieu alcalin extraites de Bacillus Licheniformis ou de Bacillus Subtilis,- bacterial proteases in neutral medium, - bacterial proteases usable in alkaline medium extracted from Bacillus Licheniformis or Bacillus Subtilis,
- endoprotéases bactériennes, ou- bacterial endoproteases, or
- enzymes pancréatiques d'origine animale. - concentration de la fraction active en petits peptides de masse moléculaire inférieure à 1 400 daltons, et- pancreatic enzymes of animal origin. concentration of the active fraction in small peptides with a molecular mass of less than 1400 daltons, and
- filtration stérilisante pour atteindre une flore mésophile totale inférieure à 100 germes /g, et une absence de levures et de moisissures.- sterilizing filtration to reach a total mesophilic flora of less than 100 germs / g, and an absence of yeasts and molds.
Les protéines végétales sont obtenues à partir notamment de céréales, d'oléagineux, de légumineuses et plus particulièrement de riz (Orysa Sativa), de soja (Glycine max), de pépins de courges, de sésame (Sesamum indicum) ou de pois (Pinu sativum) Le principe actif obtenu par la mise en œuvre du procédé présente :Vegetable proteins are obtained from cereals, oilseeds, legumes and more particularly rice (Orysa Sativa), soybeans (Glycine max), pumpkin seeds, sesame (Sesamum indicum) or peas (Pinu sativum) The active ingredient obtained by implementing the process has:
- une faible masse moléculaire inférieure à 1 400 daltons - un taux de matière sèche compris entre 20,0 et 150,0 g/1- a low molecular mass of less than 1,400 daltons - a dry matter content of between 20.0 and 150.0 g / 1
- un pH compris entre 4,0 et 10,0 et- a pH between 4.0 and 10.0 and
- une teneur en protéines comprise entre 10,0 et 100,0 g/1 Plus particulièrement :- a protein content of between 10.0 and 100.0 g / 1 More particularly:
- un taux de matière sèche compris entre 50,0 et 80,0 g/1, - un pH compris entre 5,0 et 7,0 et- a dry matter content of between 50.0 and 80.0 g / l, - a pH of between 5.0 and 7.0 and
- une teneur en protéine est comprise entre 40,0 et 60,0 g/1. La masse moléculaire est répartie de la façon suivante :- a protein content is between 40.0 and 60.0 g / 1. The molecular mass is distributed as follows:
- 20% à 60% ayant une masse moléculaire inférieure à 1400,- 20% to 60% having a molecular mass of less than 1400,
- 30%> à 50% ayant une masse moléculaire comprise entre 75 et 175 daltons, et - 0 à 5% ayant une masse moléculaire inférieure à 75 daltons.- 30%> to 50% having a molecular weight of between 75 and 175 daltons, and - 0 to 5% having a molecular weight of less than 75 daltons.
L'invention couvre aussi la composition cosmétique nutritionnelle comprenant 0,10% à 5,00% de principe actif, associé à des excipients et sous une forme galénique adaptée tel que : crème, gel, onguent, lotion, lait, émulsion ou solution. Les différentes figures annexées représentent :The invention also covers the nutritional cosmetic composition comprising 0.10% to 5.00% of active principle, associated with excipients and in a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution. The various attached figures represent:
- figure 1, une courbe de distribution des fractions peptidiques obtenues dans le cas du riz,FIG. 1, a distribution curve of the peptide fractions obtained in the case of rice,
- figures 2A-2E, des tableau de résultats sur la prolifération des f ibroblastes au cours du temps, respectivement pour du riz, du soja, des pois, des pépins de courge et du sésame,- Figures 2A-2E, table of results on the proliferation of f ibroblasts over time, respectively for rice, soybeans, peas, pumpkin seeds and sesame seeds,
- figure 3, tableau des résultats sur la prolifération de f ibroblastes comparée à d'autres compositions,- Figure 3, table of results on the proliferation of f ibroblasts compared to other compositions,
- figures 4A-4E, tableau des résultats de récupération cellulaire après un stress UV,- Figures 4A-4E, table of cell recovery results after UV stress,
- figure 5, tableau des résultats de l'activité stimulante du principe actif,- Figure 5, table of the results of the stimulating activity of the active ingredient,
- figures 6 A et 6B, des tableaux de résultats de pression partielle d'oxygène et de dioxyde de carbone,- Figures 6 A and 6B, tables of results of partial pressure of oxygen and carbon dioxide,
- figures 7A et 7B, des tableaux de résultats d'analyses sur volontaires concernant l'oxygénation tissulaire, etFIGS. 7A and 7B, tables of results of analyzes on volunteers concerning tissue oxygenation, and
- figure 8, tableau récapitulant les améliorations vis-à-vis des rides.- Figure 8, table summarizing the improvements vis-à-vis wrinkles.
1/PROCEDE D' EXTRACTION ' UN PRINCIPE ACTIF RICHE EN DI- ET TRI-PEPTIDES 1-1/Le premier produit selon l'invention dont on souhaite obtenir un concentrât riche en di et tri peptides constituant le principe actif selon l'invention, est du riz, notamment la variété Orysa Sativa. Le procédé consiste à réaliser la succession des étapes suivantes :1 / PROCESS FOR EXTRACTING AN ACTIVE PRINCIPLE RICH IN DI- AND TRI-PEPTIDES 1-1 / The first product according to the invention from which it is desired to obtain a concentrate rich in di and tri peptides constituting the active principle according to the invention, is rice, including the variety Orysa Sativa. The process consists of carrying out the following steps:
- solubilisation de protéines végétales à partir d'un concentrât de protéines dans l'eau, notamment de protéines de riz, plus particulièrement la variété Orysa Sativa, à raison d'au moins 5% en poids.- Solubilization of vegetable proteins from a protein concentrate in water, in particular rice proteins, more particularly the variety Orysa Sativa, at a rate of at least 5% by weight.
- hydrolyse(s) simultanée(s) et/ou successives de cette suspension en présence d'une ou plusieurs enzymes choisies parmi les :- simultaneous and / or successive hydrolysis (s) of this suspension in the presence of one or more enzymes chosen from:
- aminopeptidases bactériennes en milieu neutre ou acide, - proteases stomacales d'origine animale utilisables en milieu acide,- bacterial aminopeptidases in neutral or acidic medium, - stomach proteases of animal origin usable in an acid medium,
- proteases bactériennes en milieu neutre,- bacterial proteases in neutral medium,
- proteases bactériennes utilisables en milieu alcalin extraites de Bacillus Lichenifor is ou de Bacillus Subtilis, - endoprotéases bactériennes, ou- bacterial proteases usable in alkaline medium extracted from Bacillus Lichenifor is or Bacillus Subtilis, - bacterial endoproteases, or
- enzymes pancréatiques d'origine animale.- pancreatic enzymes of animal origin.
- concentration de la fraction active en petits peptides de masse moléculaire inférieure à 1 400 daltons, etconcentration of the active fraction in small peptides with a molecular mass of less than 1400 daltons, and
- filtration stérilisante pour atteindre une flore mésophile totale inférieure à 100 germes /g, et une absence de levures et de moisissures.- sterilizing filtration to reach a total mesophilic flora of less than 100 germs / g, and an absence of yeasts and molds.
On réalise dans le cas du riz une courbe représentée sur la figure 1 sur une colonne commercialisée sous la dénomination Superdex Peptide. On utilise une solution tampon phosphate 0,02 mole additionnée de 0,25 mole NaCl et on travaille à pH 7,2.In the case of rice, a curve shown in FIG. 1 is produced on a column sold under the name Superdex Peptide. Using a 0.02 mol phosphate buffer solution added with 0.25 mol NaCl and working at pH 7.2.
Le débit sur la colonne est de 0,25 ml/mn et se traduit sur papier par 0,25 cm/mn.The flow rate on the column is 0.25 ml / min and is expressed on paper by 0.25 cm / min.
On constate que la fraction inférieure à 1400 daltons est répartie de la façon suivante : Pour le principe actif riche en Di- et Tri-peptides de riz :It can be seen that the fraction less than 1400 daltons is distributed as follows: For the active principle rich in Di- and Tri-rice peptides:
- f 3 : environ 33% (1400 < masse moléculaire < 175), et- f 3: approximately 33% (1400 <molecular mass <175), and
- f 4 : environ 42% (175 < masse moléculaire < 75), et- f 4: approximately 42% (175 <molecular mass <75), and
- f 5 : environ 3% (masse moléculaire < 75), c'est-à-dire que les peptides de faibles masses moléculaires représentent au moins 60% à 75% de la fraction totale inférieure à 1400 daltons.- f 5: approximately 3% (molecular mass <75), that is to say that the peptides of low molecular masses represent at least 60% to 75% of the total fraction less than 1400 daltons.
Ces structures peptidiques selon l'invention sont spécifiques et de faible masse moléculaire, permettant ainsi les applications à la cosmétique comme le montrent les résultats qui vont suivre. 2/ CARACTERISATION DU PRINCIPE ACTIF OBTENUThese peptide structures according to the invention are specific and of low molecular mass, thus allowing applications in cosmetics as shown by the results which will follow. 2 / CHARACTERIZATION OF THE ACTIVE PRINCIPLE OBTAINED
Taux de matière sèche :Dry matter rate:
Le taux de matière sèche est obtenu par passage du principe actif extrait dans une étuve à 105°C jusqu'à obtention d'un poids constant. La quantité de matière sèche obtenue, pour chacun d'eux, est comprise entre 50 et 150 g/1.The dry matter content is obtained by passing the active ingredient extracted in an oven at 105 ° C until a constant weight is obtained. The amount of dry matter obtained, for each of them, is between 50 and 150 g / 1.
On peut citer plusieurs sources de protéines utilisées qui donnent les résultats suivants :We can cite several sources of proteins used which give the following results:
Taux de matière sèche de riz '• entre 50 et 80g/l Taux de matière sèche de pépins de courge : entre 50 et 60g/lRice dry matter rate • between 50 and 80g / l Pumpkin seed dry matter rate: between 50 and 60g / l
Taux de matière sèche de soja : entre 50 et 60g/lDry soybean content: between 50 and 60g / l
Taux de matière sèche de sésame : entre 50 et 60g/lRate of sesame dry matter: between 50 and 60g / l
Taux de matière sèche de pois : entre 90 et HOg/lPea dry matter rate: between 90 and HOg / l
Mesure du pH :PH measurement:
Le pH est mesuré par la méthode potentiometrique à température ambiante. Le pH est compris entre 4,0 et 10, plus particulièrement entre 5,0 et 7,0. pH de riz : 7,0 pH de pépins de courge : 7,0 pH de soja : 7,0 pH de sésame : 7,0 pH de pois : 7,0The pH is measured by the potentiometric method at room temperature. The pH is between 4.0 and 10, more particularly between 5.0 and 7.0. pH of rice: 7.0 pH of pumpkin seeds: 7.0 pH of soybeans: 7.0 pH of sesame: 7.0 pH of peas: 7.0
Détermination de la teneur en azote : La détermination est réalisée par la méthode de Kjeldhal ou Lowry.Determination of the nitrogen content: The determination is carried out by the method of Kjeldhal or Lowry.
La teneur en protéines déduite, quel que soit la source de protéines parmi les produits retenus, est comprise entre 10 et 100 g/1 et plus particulièrement entre 35 et 90 g/1. Teneur en azote (Di- et Tri-peptides de riz) : entre 35 et 90g/l Teneur en azote (Di- et Tri-peptides de pépins de courge) : entre 30 et 60g/l Teneur en azote (Di- et Tri-peptides de soja) : entre 30 et 60g/l Teneur en azote (Di- et Tri-peptides de sésame) : entre 30 et 60g/l Teneur en azote (Di- et Tri-peptides de pois) : entre 70 et 100g/lThe deduced protein content, whatever the source of protein among the selected products, is between 10 and 100 g / 1 and more particularly between 35 and 90 g / 1. Nitrogen content (Di- and Tri-rice peptides): between 35 and 90g / l Nitrogen content (Di- and Tri-pumpkin seed peptides): between 30 and 60g / l Nitrogen content (Di- and Tri - soy peptides): between 30 and 60g / l Nitrogen content (Di- and Tri-sesame peptides): between 30 and 60g / l Nitrogen content (Di- and Tri-pea peptides): between 70 and 100g / l
3/ EFFETS DU PRINCIPE ACTIF SUR LA PROLIFERATION DE FIBROB ASTES HUMAINS 3-1 Effets au cours du temps :3 / EFFECTS OF THE ACTIVE INGREDIENT ON THE PROLIFERATION OF FIBROB HUMAN ASTES 3-1 Effects over time:
L'étude est conduite sur des f ibroblastes humains auxquels on ajoute le principe actif riche en Di- et Tri-peptides obtenu à partir des différentes sources selon l' invention à 1%, et 2% en volume.The study is carried out on human ibroblasts to which the active ingredient rich in Di- and Tri-peptides obtained from the various sources according to the invention is added at 1%, and 2% by volume.
Pour le principe actif issu du riz, les tests sont effectués après 48 et 72 heures, tandis que les tests sont analysés seulement après 72 heures pour le principe actif issu des autres produits de base, on mesure le pourcentage de prolifération.For the active ingredient from rice, the tests are performed after 48 and 72 hours, while the tests are analyzed only after 72 hours for the active ingredient from other basic products, the percentage of proliferation is measured.
Les résultats sont consignés dans le tableau des figures 2A à 2E.The results are recorded in the table of FIGS. 2A to 2E.
Le principe actif riche en di- et tri-peptides, quelle que soit son origine, augmente fortement la prolifération des cellules, de façon dose dépendante, plus particulièrement après 72 heures de traitement.The active ingredient rich in di- and tri-peptides, whatever its origin, strongly increases the proliferation of cells, in a dose-dependent manner, more particularly after 72 hours of treatment.
3-2 Influence de la structure chimique3-2 Influence of the chemical structure
Le but est d'étudier l'influence de la structure biochimique du principe actif, sur le métabolisme de f ibroblastes humains en culture.The aim is to study the influence of the biochemical structure of the active principle on the metabolism of human f ibroblasts in culture.
A cet effet, on compare les effets de différentes compositions sur la prolifération après 72 heures de traitement avec le principe actif selon la présente invention obtenu à partir: - de riz avec 75% de peptides de masse moléculaire inférieure à 1 400 daltons.To this end, the effects of different compositions on proliferation are compared after 72 hours of treatment with the active principle according to the present invention obtained from: - rice with 75% peptides with a molecular mass of less than 1,400 daltons.
- mélange modèle d'acides aminés, sans une structuration en petits peptides,- model mixture of amino acids, without structuring into small peptides,
- solution de protéines hautement structurées, et- highly structured protein solution, and
- solution de peptides non sélectionnés avec seulement une fraction peptidique de masse moléculaire inférieure à 1400 daltons- solution of unselected peptides with only a peptide fraction of molecular mass less than 1400 daltons
On constate à travers les résultats du tableau de la figure 3, que le principe actif riche en di- et tri-peptides, selon la présente invention, augmente considérablement la prolifération des fibroblastes. Sa structure peptidique optimale est adaptée à la prolifération cellulaire. Les peptides non sélectionnés ne permettent pas d'améliorer l'activité de prolifération des cellules autant que le principe actif.It can be seen from the results in the table in FIG. 3 that the active principle rich in di- and tri-peptides, according to the present invention, considerably increases the proliferation of fibroblasts. Its optimal peptide structure is adapted to cell proliferation. The non-selected peptides do not make it possible to improve the proliferation activity of the cells as much as the active principle.
4/ EFFET U PRINCIPE ACTIF A COMPENSEE LES EFFETS D'UN STRESS SOLAIRE4 / EFFECT U ACTIVE PRINCIPLE HIDDEN THE EFFECTS OF A SOLAR STRESS
Cette étude a pour but de démontrer que le principe actif selon l'invention favorise la récupération après un stress, par exemple un stress solaire.The purpose of this study is to demonstrate that the active principle according to the invention promotes recovery after stress, for example solar stress.
Pour ce test, on mesure la viabilité cellulaire des fibroblastes humains soumis à des irradiations UVA et UVB, en présence ou non du principe actif selon la présente invention après 48 ou 72 heures.For this test, the cell viability of human fibroblasts subjected to UVA and UVB irradiation is measured, whether or not the active principle according to the present invention is present after 48 or 72 hours.
Les doses sont de 6 joules/cm2 en UVA et de 0,48 joules/cm2 en UVB et les résultats sont exprimés en densité optique à 540 nm.The doses are 6 joules / cm 2 in UVA and 0.48 joules / cm 2 in UVB and the results are expressed in optical density at 540 nm.
On constate dans les tableaux des figures 4A à 4E que le stress solaire induit une forte toxicité et provoque la mort de 60% des fibroblastes. Le principe actif à 1% permet par exemple d'augmenter le nombre de cellules en activant les fonctions métaboliques des cellules, de 35% pour le principe actif issu du riz 5/ EFFET DU PRINCIPE ACTIF SUR L' EXPRESSION DES ARNmIt can be seen in the tables of FIGS. 4A to 4E that solar stress induces high toxicity and causes the death of 60% of fibroblasts. The active ingredient at 1% makes it possible for example to increase the number of cells by activating the metabolic functions of the cells, by 35% for the active ingredient derived from rice 5 / EFFECT OF THE ACTIVE INGREDIENT ON THE EXPRESSION OF mRNAs
Le principe actif, issu des protéines de riz, a une action sur les ARN messagers codant pour les collagènes VII et III et la fibronectine en milieu nutritif carence. En effet, des fibroblastes humains sont incubés dans un milieu complet et dans un milieu nutritif carence, en présence du principe actif.The active principle, derived from rice proteins, has an action on the messenger RNA coding for collagens VII and III and fibronectin in nutrient deficiency medium. In fact, human fibroblasts are incubated in a complete medium and in a nutrient deficiency medium, in the presence of the active principle.
Les résultats obtenus sont sensiblement identiques et sont exprimés en pourcentage d'expression de l'ARN de la protéine étudiée par rapport à un témoin. Ils font l'objet du tableau de la figure 5.The results obtained are substantially identical and are expressed as a percentage of expression of the RNA of the protein studied compared to a control. They are shown in the table in Figure 5.
Le principe actif augmente de façon significative l'expression des ARNm codant pour les collagènes III, VII et la fibronectine donc des protéines constitutives du derme. Le principe actif permet de maintenir l'équilibre indispensable à la diététique cellulaire.The active ingredient significantly increases the expression of mRNAs encoding collagens III, VII and fibronectin, therefore constitutive proteins of the dermis. The active principle helps maintain the balance essential for cellular dietetics.
6/ EFFET DU PRINCIPE ACTIF SUR LE METABOLISME PAR MESURE DE SYNTHESE D* ATP Cette étude permet d'évaluer l'activité stimulante du principe actif selon la présente invention sur le stock d'adénosinetriphosphate intracellulaire. On applique sur plusieurs épidermes une formulation de chacun du principe actif à 4%> selon la présente invention, après 24 heures de contact, on dose l'ATP par luminométrie à l'aide d'un test du commerce.6 / EFFECT OF THE ACTIVE INGREDIENT ON METABOLISM BY MEASURING ATP SYNTHESIS This study makes it possible to evaluate the stimulating activity of the active ingredient according to the present invention on the stock of intracellular adenosinetriphosphate. A formulation of each of the active ingredient at 4%> according to the present invention is applied to several epidermis, after 24 hours of contact, the ATP is measured by luminometry using a commercial test.
On remarque dans le tableau de la figure 6 qui regroupe les résultats quasiment similaires, quelle qu'en soit la source, que les réserves d'ATP intracellulaire sont diminuées de 37% pour orienter l'énergie vers la synthèse cellulaire, augmentant ainsi les capacités de défense de la peau. 7/ EFFET DU PRINCIPE ACTIF SUR L'OXYGENATION TI55ULAIRENote in the table in Figure 6 which combines almost similar results, whatever the source, that intracellular ATP reserves are reduced by 37% to direct energy towards cell synthesis, thus increasing capacities defense of the skin. 7 / EFFECT OF THE ACTIVE INGREDIENT ON TI55ULAR OXYGENATION
L'objectif de cette étude est de quantifier, in vivo, sur l'homme, l'effet oxygénant du principe actif, obtenu à partir de protéines de riz. A cet effet, on mesure les pressions partielles d'oxygène et de dioxyde de carbone transcutanées sur une zone traitée avec une formulation à 4% du principe actif contre placebo.The objective of this study is to quantify, in vivo, on humans, the oxygenating effect of the active ingredient, obtained from rice proteins. For this purpose, the partial pressures of oxygen and carbon dioxide transcutaneous on a zone treated with a formulation at 4% of the active principle against placebo are measured.
Les mesures sont réalisées avant et après 28 jours d'applications biquotidiennes du principe actif. Les mesures de pression partielle sont effectuées de façon connue pour l'oxygène par mesure des variations de microcourants électriques et pour le dioxyde de carbone par détermination du pH d'un électrolyte également par mesure des variations de microcourants électriques. Les variations du pH sont proportionnelles au logarithme des variations de la pression partielle en dioxyde de carbone. Les mesures sont exprimées en mm de mercure.The measurements are taken before and after 28 days of twice-daily application of the active principle. The partial pressure measurements are carried out in a known manner for oxygen by measuring the variations in electric microcurrents and for carbon dioxide by determining the pH of an electrolyte also by measuring the variations in electric microcurrents. Changes in pH are proportional to the logarithm of changes in partial pressure of carbon dioxide. The measurements are expressed in mm of mercury.
Les tableaux des figures 7A et 7B regroupent les résultats très proches pour le principe actif et font apparaître une augmentation de la pression partielle d'oxygène chez 54% des volontaires et de la pression partielle de O2 chez 61% des volontaires. Ainsi, on constate que le principe actif tend à permettre une meilleure diffusion de l'oxygène dans les cellules et les tissus.The tables of FIGS. 7A and 7B group together the very similar results for the active principle and show an increase in the partial pressure of oxygen in 54% of the volunteers and in the partial pressure of O2 in 61% of the volunteers. Thus, it is found that the active principle tends to allow better diffusion of oxygen in cells and tissues.
8/ EFFET ANTI-RIDES DU PRINCIPE ACTIF8 / ANTI-WRINKLE EFFECT OF THE ACTIVE INGREDIENT
Le but de l'étude est de vérifier sur 20 volontaires l'efficacité anti-rides du principe actif formulé à 5% contre placebo, appliqué biquotidiennement pendant deux mois.The aim of the study is to check the anti-wrinkle efficacy of the active ingredient formulated at 5% against placebo on 20 volunteers, applied twice daily for two months.
L'étude anti-rides consiste à analyser par observation des empreintes des pattes d'oie, à l'aide d'un profilomètre muni d'un analyseur d'images. Les quatre paramètres étudiés sont :The anti-wrinkle study consists of analyzing by observing the footprints of crow's feet, using a profilometer equipped with an image analyzer. The four parameters studied are:
- surface totale ridée,- total wrinkled surface,
- longueur des rides,- length of wrinkles,
- profondeur des rides, et - nombre de rides.- depth of wrinkles, and - number of wrinkles.
Les résultats sont regroupés dans le tableau de la figure 8. L'analyse montre une forte diminution de 32% de la surface totale ridée et de 24% de la longueur des rides et la distribution confirme que cette diminution intéress 70% des volontaires. L'invention couvre aussi les compositions cosmétiques nutritionnelles incluant , 0,10% à 5,00% de principe actif, associé à des excipient, sous une forme galénique adaptée tel que : crème, gel, onguent, lotion, lait, émulsion ou solution. The results are grouped in the table in FIG. 8. The analysis shows a sharp reduction of 32% in the total wrinkled surface and in 24% in the length of the wrinkles and the distribution confirms that this reduction interests 70% of the volunteers. The invention also covers nutritional cosmetic compositions including, 0.10% to 5.00% of active principle, associated with excipients, in a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution. .

Claims

REVENDICATIONS
1. Procédé d'extraction d'un principe actif ayant une action nutritionnelle de la peau, caractérisé en ce qu'il comprend la succession des étapes suivantes :1. Method for extracting an active principle having a nutritional action from the skin, characterized in that it comprises the succession of the following stages:
- solubilisation de protéines végétales, animales ou marines dans l'eau, à raison d'au moins 5% en poids. - hydrolyse(s) simultanée(s) et/ou successives de cette suspension en présence d'une ou plusieurs enzymes choisies parmi les :- solubilization of vegetable, animal or marine proteins in water, at a rate of at least 5% by weight. - simultaneous and / or successive hydrolysis (s) of this suspension in the presence of one or more enzymes chosen from:
- aminopeptidases bactériennes en milieu neutre ou acide,- bacterial aminopeptidases in neutral or acidic medium,
- proteases stomacales d'origine animale utilisables en milieu acide,- stomach proteases of animal origin usable in an acid medium,
- proteases bactériennes en milieu neutre, - proteases bactériennes utilisables en milieu alcalin extraites de Bacillus- bacterial proteases in neutral medium, - bacterial proteases usable in alkaline medium extracted from Bacillus
Licheniformis ou de Bacillus Subtilis,Licheniformis or Bacillus Subtilis,
- endoprotéases bactériennes, ou- bacterial endoproteases, or
- enzymes pancréatiques d'origine animale.- pancreatic enzymes of animal origin.
- concentration de la fraction active en petits peptides de masse moléculaire inférieure à 1 400 daltons, etconcentration of the active fraction in small peptides with a molecular mass of less than 1400 daltons, and
- filtration stérilisante pour atteindre une flore mésophile totale inférieure à 100 germes /g, et une absence de levures et de moisissures.- sterilizing filtration to reach a total mesophilic flora of less than 100 germs / g, and an absence of yeasts and molds.
2. Procédé d'extraction d'un principe actif ayant une action nutritionnelle de la peau selon la revendication 1, caractérisé en ce que les protéines végétales sont obtenues à partir notamment de céréales, d'oléagineux, de légumineuses.2. Method for extracting an active principle having a nutritional action on the skin according to claim 1, characterized in that the vegetable proteins are obtained from cereals, oilseeds and legumes in particular.
3. Procédé d'extraction d'un principe actif ayant une action nutritionnelle de la peau selon la revendication 2, caractérisé en ce que les protéines végétales sont obtenues à partir de riz (Orysa Sativa), de soja (Glycine ax), de pépins de courges, de sésame (Sesamu indicum) ou de pois (Pinum sativum) 3. Method for extracting an active principle having a nutritional action from the skin according to claim 2, characterized in that the vegetable proteins are obtained from rice (Orysa Sativa), soy (Glycine ax), seeds squash, sesame (Sesamu indicum) or peas (Pinum sativum)
4. Principe actif obtenu par la mise en œuvre du procédé selon l'une des revendications 1 à 3, caractérisé en ce qu' il présente :4. Active principle obtained by implementing the method according to one of claims 1 to 3, characterized in that it has:
- une faible masse moléculaire inférieure à 1 400 daltons- a low molecular weight of less than 1,400 daltons
- un taux de matière sèche compris entre 20,0 et 150,0 g/1 - un pH compris entre 4,0 et 10,0 et- a dry matter content between 20.0 and 150.0 g / 1 - a pH between 4.0 and 10.0 and
- une teneur en protéines comprise entre 10,0 et 100,0 g/1- a protein content between 10.0 and 100.0 g / 1
5. Principe actif selon la revendication 4, caractérisé en ce qu'il présente :5. Active ingredient according to claim 4, characterized in that it has:
- un taux de matière sèche compris entre 50,0 et 80,0 g/1,- a dry matter content of between 50.0 and 80.0 g / 1,
- un pH compris entre 5,0 et 7,0 et - une teneur en protéine est comprise entre 40,0 et 60,0 g/l.- a pH between 5.0 and 7.0 and - a protein content is between 40.0 and 60.0 g / l.
6. Principe actif selon la revendication 4, caractérisé en ce que la masse moléculaire, est répartie de la façon suivante :6. Active ingredient according to claim 4, characterized in that the molecular mass is distributed as follows:
- 20% à 60%> ayant une masse moléculaire inférieure à 1400,- 20% to 60%> having a molecular mass of less than 1400,
- 30% à 50% ayant une masse moléculaire comprise entre 75 et 175 daltons, et - 0 à 5% ayant une masse moléculaire inférieure à 75 daltons.- 30% to 50% having a molecular weight of between 75 and 175 daltons, and - 0 to 5% having a molecular weight of less than 75 daltons.
7 . Composition cosmétique nutritionnelle, caractérisée en ce qu'elle comprend 0,10% à 5,007o de principe actif selon l'une des revendications 4 à 6, associé à des excipients et sous une forme galénique adaptée tel que : crème, gel, onguent, lotion, lait, émulsion ou solution. 7. Nutritional cosmetic composition, characterized in that it comprises 0.10% to 5.007o of active principle according to one of claims 4 to 6, associated with excipients and in a suitable dosage form such as: cream, gel, ointment, lotion, milk, emulsion or solution.
PCT/FR2002/002114 2001-06-19 2002-06-19 Method for the preparation of an active component rich in di- and tri-peptides, active component and compositions thus obtained WO2002102347A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR01/08035 2001-06-19
FR0108035A FR2825925B1 (en) 2001-06-19 2001-06-19 PROCESS FOR PREPARING AN ACTIVE INGREDIENT FROM RICE, ACTIVE INGREDIENT OBTAINED AND SUITABLE COMPOSITIONS

Publications (2)

Publication Number Publication Date
WO2002102347A2 true WO2002102347A2 (en) 2002-12-27
WO2002102347A3 WO2002102347A3 (en) 2003-12-04

Family

ID=8864499

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2002/002114 WO2002102347A2 (en) 2001-06-19 2002-06-19 Method for the preparation of an active component rich in di- and tri-peptides, active component and compositions thus obtained

Country Status (2)

Country Link
FR (1) FR2825925B1 (en)
WO (1) WO2002102347A2 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874503A1 (en) * 2004-09-01 2006-03-03 Silab Sa PROCESS FOR OBTAINING AN ACTIVE ACTIVE FIRMING AND ANTI-STRETCHING ACTIVE INGREDIENT AND THE FUNCTIONALITIES
FR2877568A1 (en) * 2004-11-10 2006-05-12 Oreal Composition, used to remodel the face and/or to limit groove formation in the face due to age, comprises a rice protein hydrolysate comprising peptides and an agent increasing the synthesis of glycosaminoglycan in a medium
WO2008009709A1 (en) 2006-07-18 2008-01-24 Laboratoires Expanscience Use of a rice protein hydrolysate as pigmenting active principle
WO2008115165A2 (en) * 2004-04-20 2008-09-25 Mgp Ingredients, Inc. Method of hydrolyzing rice protein concentrate with protease enzymes
EP2055307A1 (en) 2007-11-01 2009-05-06 Beiersdorf AG Active agent combinations made from anise fruit extract and white tea extract
EP2072038A2 (en) 2007-12-21 2009-06-24 Beiersdorf AG Active agent combinations made from aniseed fruit extract and one or more 2,3-dibenzyl butyrolactones
DE102008034265A1 (en) 2008-07-22 2010-01-28 Beiersdorf Ag Active substance combination of aniseed extract and hyaluronic acid
JP2012067042A (en) * 2010-09-24 2012-04-05 Oriza Yuka Kk Collagen production promoter and collagen gene expression promoter
US8173014B2 (en) 2002-12-02 2012-05-08 Marine Bioproducts As Apparatus for hydrolysis of a protein containing raw material and application of the resulting hydrolysis products
US20130029917A1 (en) * 2010-04-15 2013-01-31 Isp Investment Inc. Use of a peptide hydrolysate of pea as moisturizing active agent
WO2012143364A3 (en) * 2011-04-20 2013-12-05 Coty Germany Gmbh Cosmetic composition for use in increasing collagen synthesis in skin cells
DE102012211807A1 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Combination of extracts of magnolia bark extract and hyaluronic acid and their cosmetic and / or dermatological use
DE102012211797A1 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Combination of extracts of magnolia bark extract and aniseed extract and their cosmetic and / or dermatological use
DE102012219884A1 (en) 2012-10-31 2014-04-30 Beiersdorf Ag Aqueous cosmetic/dermatological composition, used to treat skin aging and to treat, care and clean skin, comprises aqueous anise fruit extract, substances with specified hydrophilic-lipophilic balance value, and polyethylene glycol-8
CN117229355A (en) * 2023-09-26 2023-12-15 华南农业大学 Active peptide derived from pumpkin seed cake, and preparation method and application thereof

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5394744B2 (en) 2005-12-08 2014-01-22 ディーエスエム アイピー アセッツ ビー.ブイ. Protective hydrocolloids for active ingredients
FR2895261B1 (en) * 2005-12-22 2009-06-05 Vincience Sa USE OF A RICE EXTRACT AS AN ACTIVE AGENT INDUCING THE SYNTHESIS OF SIRT PROTEINS IN SKIN CELLS
FR2899105B1 (en) * 2006-03-30 2012-07-27 Soc Extraction Principes Actif COSMETIC AND / OR PHARMACEUTICAL COMPOSITION COMPRISING AS ACTIVE INGREDIENT AT LEAST ONE HYDROLYZATE OF PROTEINS FROM THE POACEES AND USE OF THIS HYDROLYSAT
WO2008015341A2 (en) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
FR2906719A1 (en) * 2006-10-05 2008-04-11 Limousine D Applic Biolog Dite USE OF SUBSTANCES ACTING ON PAPILLARY DERMAS FOR ANTI-AGING ACTION.
FR2915383B1 (en) * 2007-04-27 2010-01-15 Vincience USE OF AN ACTIVE INGREDIENT FROM RICE (ORYZA SATIVA L.) FOR PREPARING A COMPOSITION FOR ACTIVATING CELL ENERGY AND PROTECTING THE SKIN FROM OXIDATIVE DAMAGE.
FR2915379B1 (en) * 2007-04-27 2012-07-13 Vincience USE OF AN ACTIVE INGREDIENT FROM RICE (ORYZA SATIVA L) FOR PREPARING A COMPOSITION INTENDED TO PROTECT MITOCHONDRIA
FR2915380B1 (en) * 2007-04-27 2012-06-08 Vincience USER OF AN ACTIVE INGREDIENT FROM RICE (ORYZA SATIVA L) FOR PREPARING A COMPOSITION INTENDED TO ACTIVATE CYTOCHROME C
FR2945444B1 (en) * 2009-05-13 2011-08-26 Limousine D Applic Biolog Ditesilab Soc Ind COSMETIC USE OF ASSETS TO IMPROVE AND / OR REPAIR THE BARRIER FUNCTION OF THE SKIN.
FR2975298B1 (en) * 2011-05-16 2013-06-28 Silab Sa COSMETIC USE OF CYNARA SCOLYMUS PEPTIDES

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320717A2 (en) * 1987-12-18 1989-06-21 ENIRICERCHE S.p.A. Process for the enzymatic hydrolysis of a protein material
DE19502167A1 (en) * 1995-01-25 1996-08-01 Henkel Kgaa Process for the production of rice protein hydrolyzates
WO1997006780A1 (en) * 1995-08-18 1997-02-27 Henkel Kommanditgesellschaft Auf Aktien Cosmetic preparations containing acyl lactylates, protein hydrolysates and protein fatty acid condensates

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05117129A (en) * 1991-10-24 1993-05-14 Kurooda Japan Kk Skin external agent
JP3171637B2 (en) * 1992-02-17 2001-05-28 共栄化学工業株式会社 Anti-aging cosmetics
JP3499336B2 (en) * 1995-09-21 2004-02-23 株式会社テクノーブル Anti-aging cosmetics

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0320717A2 (en) * 1987-12-18 1989-06-21 ENIRICERCHE S.p.A. Process for the enzymatic hydrolysis of a protein material
DE19502167A1 (en) * 1995-01-25 1996-08-01 Henkel Kgaa Process for the production of rice protein hydrolyzates
WO1997006780A1 (en) * 1995-08-18 1997-02-27 Henkel Kommanditgesellschaft Auf Aktien Cosmetic preparations containing acyl lactylates, protein hydrolysates and protein fatty acid condensates

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CHEMICAL ABSTRACTS [en ligne] Database accession no. 1993:678371 XP002197954 & JP 05 221844 A (KYOEI CHEMICAL IND) 31 août 1993 (1993-08-31) *
DATABASE WPI Week 199723 Derwent Publications Ltd., London, GB; AN 1997-255414 XP002197955 & JP 09 087133 A (SHISEIDO CO ET AL.) *
PATENT ABSTRACTS OF JAPAN vol. 17, no. 475 (C-1103) & JP 05 117129 A (KUROODA JAPAN KK), 14 mai 1993 (1993-05-14) *

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9232812B2 (en) 2002-12-02 2016-01-12 Marine Bioproducts A.S. Apparatus and method for hydrolysis of a protein containing raw material and application of the resulting hydrolysis products
US8173014B2 (en) 2002-12-02 2012-05-08 Marine Bioproducts As Apparatus for hydrolysis of a protein containing raw material and application of the resulting hydrolysis products
WO2008115165A2 (en) * 2004-04-20 2008-09-25 Mgp Ingredients, Inc. Method of hydrolyzing rice protein concentrate with protease enzymes
WO2008115165A3 (en) * 2004-04-20 2009-05-22 Mgp Ingredients Inc Method of hydrolyzing rice protein concentrate with protease enzymes
US7815948B2 (en) 2004-09-01 2010-10-19 Societe Industrielle Limousine D'application Biologique Silab Method of obtaining a firming active principle, active principle thus obtained and uses thereof
WO2006027521A2 (en) * 2004-09-01 2006-03-16 Societe Industrielle Limousine D'application Biologique, Dite Silab Method of obtaining a firming active principle and active principle thus obtained
WO2006027521A3 (en) * 2004-09-01 2006-04-27 Gique Silab Soc Ind Limousine Method of obtaining a firming active principle and active principle thus obtained
FR2874503A1 (en) * 2004-09-01 2006-03-03 Silab Sa PROCESS FOR OBTAINING AN ACTIVE ACTIVE FIRMING AND ANTI-STRETCHING ACTIVE INGREDIENT AND THE FUNCTIONALITIES
FR2877568A1 (en) * 2004-11-10 2006-05-12 Oreal Composition, used to remodel the face and/or to limit groove formation in the face due to age, comprises a rice protein hydrolysate comprising peptides and an agent increasing the synthesis of glycosaminoglycan in a medium
EP1656970A1 (en) 2004-11-10 2006-05-17 L'oreal Cosmetic composition comprising a rice protein hydrolyzate and a glycosaminoglycans synthesis promoter
WO2008009709A1 (en) 2006-07-18 2008-01-24 Laboratoires Expanscience Use of a rice protein hydrolysate as pigmenting active principle
US8231916B2 (en) 2006-07-18 2012-07-31 Laboratoires Expanscience Use of a rice protein hydrolysate as pigmenting active principle
DE102007052536A1 (en) 2007-11-01 2009-05-07 Beiersdorf Ag Active substance combinations of aniseed fruit extract and white tea extract
EP2055307A1 (en) 2007-11-01 2009-05-06 Beiersdorf AG Active agent combinations made from anise fruit extract and white tea extract
DE102007062691A1 (en) 2007-12-21 2009-06-25 Beiersdorf Ag Drug combinations of aniseed extract and one or more 2,3-Dibenzylbutyrolactonen
EP2072038A2 (en) 2007-12-21 2009-06-24 Beiersdorf AG Active agent combinations made from aniseed fruit extract and one or more 2,3-dibenzyl butyrolactones
DE102008034265A1 (en) 2008-07-22 2010-01-28 Beiersdorf Ag Active substance combination of aniseed extract and hyaluronic acid
US9199101B2 (en) * 2010-04-15 2015-12-01 Isp Investments Inc. Use of a peptide hydrolysate of pea as moisturizing active agent
US20130029917A1 (en) * 2010-04-15 2013-01-31 Isp Investment Inc. Use of a peptide hydrolysate of pea as moisturizing active agent
JP2012067042A (en) * 2010-09-24 2012-04-05 Oriza Yuka Kk Collagen production promoter and collagen gene expression promoter
WO2012143364A3 (en) * 2011-04-20 2013-12-05 Coty Germany Gmbh Cosmetic composition for use in increasing collagen synthesis in skin cells
US9572768B2 (en) 2011-04-20 2017-02-21 Coty Germany Gmbh Cosmetic composition for use in increasing the collagen synthesis in skin cells
WO2014005818A2 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Active ingredient combinations of magnolia bark extract and hyaluronic acid and the cosmetic and/or dermatological use thereof
DE102012211797A1 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Combination of extracts of magnolia bark extract and aniseed extract and their cosmetic and / or dermatological use
WO2014005815A2 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Active ingredient combinations of magnolia bark extract and anise fruit extract and the cosmetic and/or dermatological use thereof
DE102012211807A1 (en) 2012-07-06 2014-01-09 Beiersdorf Ag Combination of extracts of magnolia bark extract and hyaluronic acid and their cosmetic and / or dermatological use
US9402801B2 (en) 2012-07-06 2016-08-02 Beiersdorf Ag Active ingredient combinations of magnolia bark extract and hyaluronic acid and the cosmetic and/or dermatological use thereof
DE102012219884A1 (en) 2012-10-31 2014-04-30 Beiersdorf Ag Aqueous cosmetic/dermatological composition, used to treat skin aging and to treat, care and clean skin, comprises aqueous anise fruit extract, substances with specified hydrophilic-lipophilic balance value, and polyethylene glycol-8
CN117229355A (en) * 2023-09-26 2023-12-15 华南农业大学 Active peptide derived from pumpkin seed cake, and preparation method and application thereof

Also Published As

Publication number Publication date
FR2825925A1 (en) 2002-12-20
FR2825925B1 (en) 2005-01-28
WO2002102347A3 (en) 2003-12-04

Similar Documents

Publication Publication Date Title
WO2002102347A2 (en) Method for the preparation of an active component rich in di- and tri-peptides, active component and compositions thus obtained
Wu et al. Bioactive protein/peptides of flaxseed: A review
EP2419438B1 (en) Cosmetic and/or pharmaceutical composition comprising a peptidic hydrolysate that can reinforce the barrier function
EP2018149B1 (en) Cosmetic active ingredient composed of arginine ferrulate and a microalgae extract and its uses
JP4740511B2 (en) Bean product-containing composition
FR2944797A1 (en) PEPTIDE HYDROLYSATS ACTIVATORS OF PROTEASOME AND COMPOSITIONS CONTAINING SAME
JP4767474B2 (en) Bean product
WO2009043991A2 (en) Use of an active principle from flax for use in a composition for activating cytochrome c
EP0975322B1 (en) Use in cosmetics of a protein fraction extracted from okra seeds
JP2008056664A (en) Composition promoting collagen production and/or promoting fibroblast proliferation
Gaikwad et al. Antioxidant and anti-hypertensive bioactive peptides from Indian mackerel fish waste
Stramarkou et al. Recovery of functional pigments from four different species of microalgae
US10842164B2 (en) Composition containing amino acids and process for producing same
Noviyanti et al. Effect of germination on free radical scavenging activities and angiotensin I-converting enzyme inhibitory of melinjo (Gnetum gnemon L) seed proteins
JP2011116761A (en) Antioxidative peptide derived from royal jelly
WO2011055032A2 (en) Use of a composition comprising a non-fermented rice peptide hydrolysate for stimulating hair growth
Prakash et al. Protein and amino acid composition of some wild leguminous seeds
JP2024504517A (en) cosmetic composition
FR2796839A1 (en) USE OF A PROTEIN FRACTION OF THE SEED OF THE VIGNA TRILOBATA PLANT IN A COSMETIC OR DERMOPHARMACEUTICAL COMPOSITION
EP1778162A1 (en) Use of a triticum monococcum extract as active principe in a cosmetic and/or pharmaceutical composition
FR3072031B1 (en) ACTIVE COSMETIC PRINCIPLE BASED ON GERMINED SEED EXTRACTS
KR101373191B1 (en) Fermented microalgae for antioxidant effect and a functional product composition containing the same
FR3101544A1 (en) COSMETIC OR DERMATOLOGICAL TREATMENT BASED ON PEPTIDE (S) OF THE SKIN AND ITS PHANERES
WO2014029948A2 (en) Flax extract and cosmetic composition comprising said extract for increasing the level of intracellular coenzyme q10
CA2278226C (en) Cosmetic or dermo-phamaceutical products compatible with cutaneous ecology

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP